Loading
Sana Biotechnology, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by CRANDELL KEITH, was filed 12 Feb 2024.
Insider Decl.
135
Thresholds
n/a
Buy Volume
€6M
4 ops. · all time
Sell Volume
€12M
31 ops. · all time
Who traded when
BuySaleFMR LLC4 sales
Since the insiders bought
- -54.7%Entry US$6.27 · Close at T+365 US$2.84
- -54.7%Entry US$6.27 · Close at T+365 US$2.84
- -56.6%Entry US$7.49 · Close at T+365 US$3.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$2.36
Analyst consensus
7 analysts1.44/5
US$6.00Target US$8.43(+257%)US$12.00
Income statement
EBITDA-US$193M
Net income-US$244.2M0.0% margin
Valuation
PER (forward)-4.3x
P/Book4.6x
Beta2.19
Balance sheet & cash
Market capUS$706.5M
Total debtUS$78.9M
Free Cash Flow-US$144.8M
Debt / Equity52%
Profitability & ownership
ROE-152.9%
ROA-29.2%
% insiders6.1%
% institutions77.7%
Last declaration on 6 October 2026
Declarations135 total
8,680 shares0Common StockSEC:0001480212-26-000010:0
125,000 shares0Common StockSEC:0002115339-26-000004:0
41,158 shares@ US$4.110.019% mcap100.0% of flowCommon StockSEC:0002115339-26-000004:1
6,297 shares0Common StockSEC:0001480212-26-000008:0
7,763 shares0Common StockSEC:0001480212-26-000004:0
3,250 shares0Common StockSEC:0001568605-26-000008:1
50,000 shares0Common StockSEC:0001627387-26-000004:1
3,342 shares@ US$3.1319.4% of flowCommon StockSEC:0001568605-26-000008:2
1,045 shares@ US$3.106.0% of flowCommon StockSEC:0001568605-26-000008:3
11,526 shares@ US$3.1332.6% of flowCommon StockSEC:0001627387-26-000004:2
12,819 shares@ US$3.1035.9% of flowCommon StockSEC:0001627387-26-000004:3
41,666 shares0Common StockSEC:0001627387-26-000004:0
10,416 shares0Common StockSEC:0001568605-26-000008:0
491 shares@ US$3.913.5% of flowCommon StockSEC:0001568605-26-000004:1
1,525 shares0Common StockSEC:0001568605-26-000004:0
2,407 shares@ US$4.2718.7% of flowCommon StockSEC:0001568605-26-000002:1
6,157 shares0Common StockSEC:0001480212-26-000002:0
7,500 shares0Common StockSEC:0001568605-26-000002:0
873 shares@ US$5.228.3% of flowCommon StockSEC:0001568605-25-000007:1
3,400 shares0Common StockSEC:0001568605-25-000007:0
10,000 shares0Common StockSEC:0001568605-25-000005:2
2,565 shares@ US$4.4420.8% of flowCommon StockSEC:0001568605-25-000005:3
2,567 shares@ US$2.3211.1% of flowCommon StockSEC:0001568605-25-000005:1
10,000 shares0Common StockSEC:0001568605-25-000005:0
5,628 shares0Common StockSEC:0001480212-25-000006:0
25 of 135 declarations
About Sana Biotechnology, Inc.
On February 8, 2024, three insiders of Sana Biotechnology, Inc. bought on the same day, for EUR 12,992,132 in total: Keith Crandell, ARCH Venture Fund X, L.P. (both 10% owners) and Robert Nelsen, a director, each report EUR 3,712,036. These are the largest purchases in the record, which counts 6 purchases worth EUR 13.6 million (median EUR 2,784,030).
Sales are more numerous: 31 worth EUR 12.1 million (median EUR 157,072), so purchases are 16% of open-market trades. Flagship Ventures Fund V General Partner LLC sold EUR 1,881,497 on May 24, 2023 and EUR 1,069,645 on June 6, 2023; Sunil Agarwal (EVP, Head of Development & CMO) EUR 1,287,441 on September 15, 2021. Christian Hordo (EVP, Chief Business Officer) files 16 filings including 11 sales.
Read moreShow less
This US healthcare company, valued at USD 706.5 million and 6.1% held by insiders, has 133 filings from 19 filers, 40 of them in 2021. The record also lists 44 grants and 21 option exercises. Hans Edgar Bishop, a director, files 20 filings, with neither purchase nor sale. The last twelve months have 24 filings, with no purchase or sale.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
